Global Biopharma Insights

Find the report behind your next decision

Syndicated reports on market outlook, epidemiology, emerging therapies, current treatment and market access, across oncology, rare and non-oncology indications.

Report Store Offer

Save 10% when you start with a free sample

Preview the scope and sample pages of any report in the store, then get 10% off when you buy it.

EpiLansis

Know exactly how many patients you can reach

Validated patient numbers, funnels and disease burden for 450+ indications across 30+ countries.

PayerPro360

Payer insight in as little as three weeks

Payer research across 31+ markets to shape your pricing, reimbursement and launch strategy.

Portfolio Optimization

Know which assets to back before the budget is spent

Weigh every asset on clinical, commercial, regulatory and competitive evidence, and invest where value is highest.

Primary Market Research

Hear directly from the physicians who treat

Test your assumptions with interviews and surveys drawn from our 8,500+ physician expert panel.

Market Forecasting

Forecasts your team can plan a launch around

Patient-based forecasts that combine epidemiology, treatment dynamics, pricing and competition.

Conference Coverage

Every key congress, distilled for your team

Live coverage of major meetings such as ESMO 2026, with the data and takeaways that matter to you.

Browse by report type

Filters

No matching options.
No matching options.
No matching options.
No matching options.
Add us as a preferred source on Google

See Thelansis insights first in Google’s Top Stories when you search the topics you follow.

Custom research
Can't find your indication?

We tailor reports to the indication, markets and questions you need.

Need help or guidance?

Not sure which report fits your question? Our team will point you to the right one.

Recently viewed reports

Reports you open will show here.

Showing 1 to 10 of 2,616 reports

Loading...
Unmet Needs & TPP Non-Oncology Indications

Dry Age-Related Macular Degeneration – Emerging Therapy, with Unmet Needs and TPP Insights Report –...

Thelansis’s “Dry Age-Related Macular Degeneration Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product pr...

  • Updated: 7 Nov 2026
  • Delivery: 48 to 72 hours
Market Outlook & Forecast Non-Oncology Indications

Dry Age-Related Macular Degeneration – Market Outlook, Epidemiology, Competitive Landscape, and Mark...

Thelansis’s “Dry Age-Related Macular Degeneration Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription shar...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Unmet Needs & TPP Non-Oncology Indications

Generalized Myasthenia Gravis (gMG) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2...

Thelansis’s “Generalized Myasthenia Gravis (gMG) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product pro...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Unmet Needs & TPP Non-Oncology Indications

Niemann-Pick Type C (NPC) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026

Thelansis’s “Niemann-Pick Type C (NPC) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPP...

  • Updated: 5 Nov 2026
  • Delivery: 48 to 72 hours
Unmet Needs & TPP Non-Oncology Indications

Progressive Multiple Sclerosis (PMS) – Emerging Therapy, with Unmet Needs and TPP Insights Report –...

Thelansis’s “Progressive Multiple Sclerosis (PMS) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product pr...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Market Outlook & Forecast Non-Oncology Indications

Progressive Multiple Sclerosis (PMS) – Market Outlook, Epidemiology, Competitive Landscape, and Mark...

Thelansis’s “Progressive Multiple Sclerosis (PMS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription shar...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Need several reports? Bundle them and we will send you a quote with a bundle discount.
Unmet Needs & TPP Oncology Indications

Myelofibrosis – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026

Thelansis’s “Myelofibrosis Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), trial de...

  • Updated: 5 Nov 2026
  • Delivery: 48 to 72 hours
Market Outlook & Forecast Oncology Indications

Myelofibrosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 20...

Thelansis’s “Myelofibrosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive...

  • Updated: 5 Nov 2026
  • Delivery: 48 to 72 hours
Unmet Needs & TPP Non-Oncology Indications

Secondary Progressive Multiple Sclerosis (SPMS) – Emerging Therapy, with Unmet Needs and TPP Insight...

Thelansis’s “Secondary Progressive Multiple Sclerosis (SPMS) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Unmet Needs & TPP Non-Oncology Indications

Cystic Fibrosis (CF) – Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026

Thelansis’s “Cystic Fibrosis (CF) Emerging Therapy, with Unmet Needs and TPP Insights Report – 2026″ provides a comprehensive analysis of the emerging competitive landscape, unmet needs, target product profiles (TPPs), t...

  • Updated: 6 Nov 2026
  • Delivery: 48 to 72 hours
Custom research

Can't find the exact report you need?

Tell us what you are looking for and we will tailor the research to your indication, markets and questions.

Build your request

    I need for covering .

    Prefer to talk it through? Email clientsupport@thelansis.com

    Thanks, , we have your request

    You asked for for covering . We will reply to .


      We use your details only to send what you asked for. Read our privacy policy.

      Request your free sample

      Tell us where to send it. It takes under a minute.
       

          Request Bundle Discount

          Get exclusive pricing for report bundles.

          *
          Required fields are marked












          Your information is secure and confidential.

          Contact Us

          Fill in your details and our expert consultants will get in touch with you.

            * Required fields are marked

              Request Epilansis Demo

              See how Epilansis can support your business.

              *
              Required fields are marked












              Your information is secure and confidential.